2021
DOI: 10.1016/j.urolonc.2021.02.013
|View full text |Cite
|
Sign up to set email alerts
|

Expression of functional E-selectin ligands on the plasma membrane of carcinoma cells correlates with poor prognosis in clear cell renal cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 21 publications
0
7
2
Order By: Relevance
“…19 Membrane expression of respective KM93 and CA19-9 was scored as 0, 1+, 2+ or 3+, as described. 17,19 All tissue specimens were independently scored by the two authors of this article (M.T. and Y.F.)…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…19 Membrane expression of respective KM93 and CA19-9 was scored as 0, 1+, 2+ or 3+, as described. 17,19 All tissue specimens were independently scored by the two authors of this article (M.T. and Y.F.)…”
Section: Methodsmentioning
confidence: 99%
“…We previously showed that expression of sLe x /sLe a correlated with poor prognosis in ccRCC using HECA-452 monoclonal antibody, which recognises both sLe x and sLe a . 17 Using KM93 and CA19-9 monoclonal antibodies, which specifically recognise sLe x and sLe a , respectively, we investigated whether sLe x and sLe a (quantified in this study by measurement of their membrane expression) could be proposed as prognostic biomarkers in ccRCC patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…E-selectin plays an important role in the process of inflammation by facilitating the adhesion and migration of immune cells to sites of inflammation [39]. Recent studies have shown that E-selectin may also be involved in cancer, since it was found to be upregulated in various types of cancer including breast [24,40], lung [41], and pancreatic cancer [42], and its expression levels are associated with more aggressive tumors and poorer prognosis in cancer patients [43].…”
Section: Introductionmentioning
confidence: 99%
“…5 Under pathologic conditions, E-selectin also binds to sialyl Lewis a (sLe a , a structural isomer of sLe x also known as CA19-9), S i a α 2 → 3 G a l β 1 → 3 ( Fu c α 1 → 4 ) G l c N Ac β 1 → R , expressed on circulating tumor cells and can contribute to formation of hematogenous metastasis. 6 Taking advantage of this sLe x /sLe a -specific carbohydratebinding property of E-selectin, we previously used an E-selectin•IgM chimera, which is a soluble form of E-selectin, to functionally probe sLe x and/or sLe a in formalin-fixed, paraffin-embedded (FFPE) tissue sections of various human diseases, including chronic Helicobacter pylori gastritis, 7 ulcerative colitis, 8 testicular seminoma, 9 bladder urothelial carcinoma, 10 papillary thyroid carcinoma, 11 clear cell renal cell carcinoma, 12 and most recently, angioimmunoblastic T-cell lymphoma. 13 Immunohistological analysis of the E-selectin molecule itself, however, has been hampered by lack of E-selectin-specific monoclonal antibodies capable of staining FFPE tissue sections; thus researchers had no choice but to use frozen tissue sections.…”
Section: Introductionmentioning
confidence: 99%